| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.943746 |
| 003 | CaOODSP |
| 005 | 20241213160418 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 241003e202410##onca o f000 0 eng d |
| 020 | |a9780660738864 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aD2-676/2024E-PDF |
| 245 | 00|aEvaluation of the Strategic Medical Countermeasures Program : |bsummary report. |
| 264 | 1|a[Ottawa] : |bNational Defence = Défense nationale, |cOctober 2024. |
| 300 | |a1 online resource (4 pages) : |billustrations |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aCaption title. |
| 500 | |a"1258-3-071." |
| 500 | |a"Reviewed by ADM(RS) in accordance with the Access to Information Act. Information UNCLASSIFIED." |
| 500 | |aIssued also in French under title: Évaluation du Programme de contre-mesures médicales stratégiques : rapport sommaire. |
| 520 | |a"The SMCP evaluation covers Fiscal Year (FY) 2019/20 to 2023/24. The evaluation complies with the 2016 Treasury Board Policy on Results. The areas of assessment include: the relevance of the program in the current threat environment; SMCP’s ability to acquire and sustain a high readiness strategic stockpile; and support that enablers provided to the program"--Page 1. |
| 650 | 0|aMedicine, Preventive|zCanada|xEvaluation. |
| 650 | 0|aMedicine, Military|zCanada. |
| 710 | 1 |aCanada. |bDepartment of National Defence, |eissuing body. |
| 775 | 08|tÉvaluation du Programme de contre-mesures médicales stratégiques : |w(CaOODSP)9.943747 |
| 856 | 40|qPDF|s235 KB|uhttps://publications.gc.ca/collections/collection_2024/mdn-dnd/D2-676-2024-eng.pdf |
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/department-national-defence/corporate/reports-publications/audit-evaluation/eval-strategic-med-countermeasures-prog-summary.html |